Home Medicine Observations with Regard to the National Kidney Foundation K/DOQI Clinical Practice Guidelines Concerning Serum Transthyretin in Chronic Renal Failure
Article
Licensed
Unlicensed Requires Authentication

Observations with Regard to the National Kidney Foundation K/DOQI Clinical Practice Guidelines Concerning Serum Transthyretin in Chronic Renal Failure

  • Joel D. Kopple , Rajnish Mehrotra , Oppatham Suppasyndh and Kamyar Kalantar-Zadeh
Published/Copyright: June 1, 2005
Become an author with De Gruyter Brill
Clinical Chemistry and Laboratory Medicine (CCLM)
From the journal Volume 40 Issue 12

Abstract

The National Kidney Foundation K/DOQI Guidelines state that, “Serum prealbumin is a valid and clinically useful measure of protein-energy nutritional status in maintenance dialysis (MD) patients.” Prealbumin, also known as serum transthyretin (TTR), was not recommended as a nutritional parameter of the same usefulness as the serum albumin. This decision was made, in part, because published research at that time suggested that serum TTR was not a more sensitive index of nutritional status than serum albumin and there was much more clinical and research experience with serum albumin as a nutritional and inflammatory marker. Evidence, including more recently published research data, which is reviewed in this paper has led to the following conclusions by the current authors: 1) In MD patients either protein-energy malnutrition or inflammation can lead to a reduction in serum TTR concentrations. 2) Hence, in MD patients, serum TTR concentrations can be used as a measure of both nutritional and inflammatory status. 3) Serum TTR concentrations are typically increased in MD patients. 4) In maintenance hemodialysis (MHD) patients, serum TTR is a risk factor for mortality that is somewhat independent of serum albumin. 5) Current epidemiological evidence suggests that a serum TTR value of 25 or 30 mg/dl or greater is associated with increased survival and, hence, is desirable in MHD patients. 6) MHD patients with serum TTR levels less than 25–30 mg/dl should be evaluated for protein-energy malnutrition and inflammation.

:
Published Online: 2005-06-01
Published in Print: 2002-12-10

Copyright © 2002 by Walter de Gruyter GmbH & Co. KG

Articles in the same Issue

  1. Author Index
  2. Subject Index
  3. Contents
  4. Historical Aspects and Perspectives in Transthyretin Research
  5. Transthyretin from Discovery to Now
  6. The Evolution of Transthyretin Synthesis in Vertebrate Liver, in Primitive Eukaryotes and in Bacteria
  7. The Evolution of Transthyretin Synthesis in the Choroid Plexus
  8. Hepatic Synthesis, Maturation and Complex Formation between Retinol-Binding Protein and Transthyretin
  9. Synthesis and Structural Analysis of the N-Terminal Domain of the Thyroid Hormone-Binding Protein Transthyretin
  10. Three-Dimensional Structure of the Transthyretin-Retinol-Binding Protein Complex
  11. Mechanisms of Molecular Recognition: Crystal Structure Analysis of Human and Rat Transthyretin Inhibitor Complexes
  12. Transthyretin in Fish: State of the Art
  13. The Effects of Endocrine-Disrupting Chemicals on Thyroid Hormone Binding to Xenopus laevis Transthyretin and Thyroid Hormone Receptor
  14. Clinical Picture and Outcome of Transthyretin-Related Familial Amyloid Polyneuropathy (FAP) in Japanese Patients
  15. Laboratory Assessment of Transthyretin Amyloidosis
  16. Amyloid: Morphology and Toxicity
  17. Historical Overview of Analytical Methods for the Measurement of Transthyretin
  18. Nutritional Regulation of Visceral Markers in Rat Liver and Cultured Hepatoma Cells
  19. Significance of Transthyretin in Protein Metabolism
  20. Transthyretin as a Thyroid Hormone Carrier: Function Revisited
  21. The Molar Ratio of Retinol-Binding Protein to Transthyretin in the Assessment of Vitamin A Status in Adults. Proposal of a Cut-off Point
  22. Observations with Regard to the National Kidney Foundation K/DOQI Clinical Practice Guidelines Concerning Serum Transthyretin in Chronic Renal Failure
  23. Metabolism and Clinical Interest of Serum Transthyretin (Prealbumin) in Dialysis Patients
  24. Protein Status in Pancreatitis – Transthyretin Is a Sensitive Biomarker of Malnutrition in Acute and Chronic Pancreatitis
  25. Assessment of Nutritional Status in Organ Transplant: Is Transthyretin a Reliable Indicator?
  26. Body Composition and Nutritional Parameters in HIV and AIDS Patients
  27. C-Reactive Protein to Transthyretin Ratio for the Early Diagnosis and Follow-up of Postoperative Infection
  28. The Prognostic Value of Nutritional and Inflammatory Indices in Critically Ill Patients with Acute Respiratory Failure
  29. Transthyretin: Its Response to Malnutrition and Stress Injury. Clinical Usefulness and Economic Implications
  30. Transthyretin Measurement as a Screening Tool for Protein Calorie Malnutrition in Emergency Hospital Admissions
  31. Outcomes of Continuous Process Improvement of a Nutritional Care Program Incorporating TTR Measurement
  32. The Role of Visceral Protein Markers in Protein Calorie Malnutrition
  33. Acknowledgement
  34. Meetings
Downloaded on 8.12.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2002.225/html
Scroll to top button